Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-beta-4-fragment

Ac-SDKP, Goralatide, Seraspenide

A tetrapeptide fragment of thymosin beta-4 that inhibits inflammation, reduces fibrosis, and regulates hematopoietic stem cell proliferation.

Molecular Profile
Formula C20H33N5O9
Mol. Weight 487.5 g/mol
Sequence Gly-Glu-Pro-Pro...
Route
Intravenous (IV)
0.25-2.5 pmol/kg/min (infusion, human research)
INT
Subcutaneous (SC)
1.6 mg/kg/day (animal models)
SUB

How It Works

How It Works: Thymosin Beta-4 Fragment (Ac-SDKP) functions as an anti-inflammatory and anti-fibrotic agent by modulating key cellular pathways, primarily through inhibition of angiotensin-converting enzyme and stem cell regulation.

  • Inhibits hematopoietic stem cell proliferation by blocking entry into the S-phase of the cell cycle.
  • Reduces fibrosis by suppressing TGF-beta signaling and Smad activation in fibroblasts.
  • Exerts anti-inflammatory effects by decreasing pro-inflammatory cytokine production and neutrophil activity.
  • Protects against organ damage in conditions like hypertension by modulating renin-angiotensin system.

Latest Clinical Trials

Completed PHASE4 NCT00224549

PHARES Study: Management of Resistant Hypertension

Assistance Publique - HĂ´pitaux de Paris
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE1, PHASE2 NCT01588756

Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)

Assistance Publique - HĂ´pitaux de Paris
INTERVENTIONAL
Updated Dec 15, 2025
Completed PHASE1 NCT01485900

Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment

Sanofi
INTERVENTIONAL
Updated Dec 15, 2025
View All Clinical Trials

Latest Studies

Utility 1
pubmed Aug 28, 2025

Electron Capture Dissociation for Discovery Top-Down Proteomics of Peptides and Small Proteins on Chromatographic Time Scales.

Manly. Lester S LS; Roberts. Anne M AM; Beckman. Joseph S JS; Roberts. Blaine R...

The paper describes a fancy mass‑spectrometry technique that can read the exact sequence and tiny chemical changes of small proteins, including thymosin‑beta‑4, but it doesn’t give any advice on how to use the peptide for health or performance.

Utility 2
pubmed Sep 24, 2024

Equine Doping Controls of Thymosin <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>&#x3b2;</mml:mi></mml:math> 4: A Population Study and Strategy for Misuse Detection.

Delcourt. Vivian V; Garcia. Patrice P; Chabot. Benjamin B; Aber. Nina N; Pescher...

The researchers measured the natural amount of thymosin‑beta‑4 (TB4) in horse blood and found it’s about the same no matter the horse’s sex, age, or breed. They also discovered that if blood isn’t separated from cells and is kept at 4 °C, TB4 levels rise quickly because cells break open. Finally, they showed they can spot a synthetic TB4 product in a horse’s plasma after just one dose by looking for a tiny impurity that only shows up in lab‑made versions.

Utility 2
pubmed Jun 25, 2021

Effects of thymosin &#x3b2;4-derived peptides on migration and invasion of ovarian cancer cells.

Yoon. Hyung Joon HJ; Oh. Young Lim YL; Ko. Eun-Ji EJ; Kang. Ahyun A; Eo. Wan Kyu...

The study shows that thymosin‑beta‑4 and its short fragment peptides make ovarian cancer cells move, invade, and grow faster, likely by raising a protein called RACK‑1. For people experimenting with peptides, this suggests that using thymosin‑beta‑4 could potentially promote cancer cell activity, not improve health.

Browse All Studies